Home › Research › Lewy body dementia
The role of TDP-43 propagation in neurodegenerative diseases: integrating insights from clinical and experimental studies
Jo M, Lee S, Jeon YM, Kim S, Kwon Y, Kim HJ.. Experimental & molecular medicine, 2020-10-13
Topic: Brain proteins, microglia and lab models
Plain-language summary
TAR DNA-binding protein 43 (TDP-43) is a highly conserved nuclear RNA/DNA-binding protein involved in the regulation of RNA processing. The accumulation of TDP-43 aggregates in the central nervous system is a common feature of many neurodegenerative diseases, such as amyotrophic lateral sclerosis (ALS), frontotemporal dementia (FTD), Alzheimer's disease (AD), and limbic predominant age-related TDP-43 encephalopathy (LATE). Accumulating evidence suggests that prion-like spreading of aberrant protein aggregates composed of tau, amyloid-β, and α-synuclein is involved in the progression of neurodegenerative diseases such as AD and PD. Similar to those of prion-like proteins, pathological aggregates of TDP-43 can be transferred from cell-to-cell in a seed-dependent and self-templating manner. Here, we review clinical and experimental studies supporting the prion-like spreading of misfolded TDP-43 and discuss the molecular mechanisms underlying the propagation of these pathological aggregated proteins. The idea that misfolded TDP-43 spreads in a prion-like manner between cells may guide novel therapeutic strategies for TDP-43-associated neurodegenerative diseases.
What this study adds
Evidence grade: Low
This is a narrative review. This review describes evidence that misfolded TDP-43 can spread from cell to cell in a seed-dependent, self-templating, prion-like manner in diseases such as ALS, FTD, Alzheimer's disease, and LATE. It suggests this idea may guide novel therapeutic strategies for TDP-43-associated neurodegenerative diseases, but no treatment or cure is reported.
Taken from this record’s own fields, not from reading the paper. The grade is assigned from the abstract’s wording; what that means.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
Jo, M., Lee, S., Jeon, Y. M., Kim, S., Kwon, Y., & Kim, H. J. (2020). The role of TDP-43 propagation in neurodegenerative diseases: integrating insights from clinical and experimental studies. Experimental & molecular medicine. https://doi.org/10.1038/s12276-020-00513-7
Vancouver
Jo M, Lee S, Jeon YM, Kim S, Kwon Y, Kim HJ. The role of TDP-43 propagation in neurodegenerative diseases: integrating insights from clinical and experimental studies. Experimental & molecular medicine. 2020. doi:10.1038/s12276-020-00513-7. PMID: 33051572.
BibTeX
@article{jo2020-33051572,
author = {Jo, M. and Lee, S. and Jeon, Y. M. and Kim, S. and Kwon, Y. and Kim, H. J.},
title = {{The role of TDP-43 propagation in neurodegenerative diseases: integrating insights from clinical and experimental studies}},
journal = {Experimental \& molecular medicine},
year = {2020},
doi = {10.1038/s12276-020-00513-7},
pmid = {33051572},
url = {https://doi.org/10.1038/s12276-020-00513-7}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. Check the citation against the original before you use it.
Key findings
- Accumulating evidence suggests that prion-like spreading of aberrant protein aggregates composed of tau, amyloid-β, and α-synuclein is involved in the progression of neurodegenerative diseases such as AD and PD.
Why it matters
This review describes evidence that misfolded TDP-43 can spread from cell to cell in a seed-dependent, self-templating, prion-like manner in diseases such as ALS, FTD, Alzheimer's disease, and LATE. It suggests this idea may guide novel therapeutic strategies for TDP-43-associated neurodegenerative diseases, but no treatment or cure is reported.
Study details
- Evidence strengthLow
How this study scored 51/100
Published in a peer-reviewed journal. Scored zero for study design, sample size, effect reported, studied in people and randomized / blinded because the record does not state it.
| Component | Points | Why |
|---|---|---|
| Journal tier | 7 / 10 | Tier 3 — peer-reviewed journal (Experimental & molecular medicine) |
| Journal's citation record | 2 / 4 | Experimental & Molecular Medicine: journal h-index 181 (OpenAlex, 2026-10-29) |
| Study design | 0 / 12 | No study design recorded — scores zero, not guessed (not stated in the record — scored 0) |
| Strength of evidence | 1 / 5 | Rated “low” in our summary |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 2 / 5 | 2020 — within 10 year(s) of the newest study here |
| Sample size | 0 / 4 | Participant count not stated — scores zero (not stated in the record — scored 0) |
| Effect reported | 0 / 3 | No effect size reported — scores zero (not stated in the record — scored 0) |
| Studied in people | 0 / 3 | Not stated whether this was studied in people — scores zero (not stated in the record — scored 0) |
| Randomized / blinded | 0 / 2 | No randomization or blinding stated — scores zero (not stated in the record — scored 0) |
| Times cited | 6 / 7 | Cited 401 times (OpenAlex, 2026-10-10) |
| Citations per year | 5 / 5 | 50.1 citations a year over 8 year(s) since 2020 |
| Impact for its field and year | 4 / 6 | Cited 12.0× the average for papers of its field and year (OpenAlex FWCI) |
| Cited by studies here | 3 / 6 | Cited by 18 other studies in this library |
| Still being cited | 4 / 4 | Cited 272 times in 2024–2026 (2026 still in progress; OpenAlex) |
| Senior author's track record | 2 / 4 | Last-listed author Hyung‐Jun Kim: h-index 20 (OpenAlex, whole career) |
| Institution's track record | 0 / 3 | Daegu Gyeongbuk Institute of Science and Technology: institution h-index 263 (OpenAlex) |
| Multicenter collaboration | 1 / 3 | OpenAlex lists 2 institution(s) in 1 country |
| Indexed in PubMed | 2 / 2 | Indexed in PubMed (PMID 33051572) |
| Free to read | 2 / 2 | Free to read |
| Total | 51 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
- DOI: 10.1038/s12276-020-00513-7
- PubMed: 33051572
- Original source →
- Free full text: Experimental & Molecular Medicine →
Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).
Related
Studies in the library that share something with this one. The line above each title says what.
Studies this one cites
Referenced by this study and also in the alzhub library, so you can read them here. Showing 12 of 31.
Later studies that cite this one
18 studies in the alzhub library list this one in their references. Showing the 8 highest-scoring.
Related studies in Lewy body dementia from nearby years
Also tagged “tdp-43”
1,150 studies in the library carry the topic tag “tdp-43”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 1,150 tagged studies.